Study findings suggest using the drug PF-06409577 to restore CDX2 in colon cancers could cut risk of recurrence and death by up to 50%.
In an interview with CNBC, El-Erian emphasized that the current investment surge in artificial intelligence technologies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback